HOME >> MEDICINE >> NEWS
Late-breaking Digestive Disease Week news

Los Angeles, CA Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that late-breaking news was presented during the Digestive Disease Week (DDW) conference in Los Angeles, CA, about phase 3 data of methylnaltrexone, a drug subcutaneously delivered in patients with advanced illness.

The data are from the second pivotal phase 3 clinical trial of the investigational drug methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illnesses, such as cancer and cardiovascular disease. Results presented at DDW showed that nearly half of constipated patients with advanced illness experienced laxation (bowel movement) within four hours of receiving their first dose of methylnaltrexone (0.15 mg/kg), and more than 70% responded by the end of the first week of treatment (0.15 mg/kg qod). For those who responded, the median time to laxation following methylnaltrexone treatment was 30 minutes, and there were no reports of diminished analgesia due to study medication.

"In order to provide the most compassionate care possible, health care professionals want to focus on aggressive pain management without the worry of opioid-induced bowel dysfunction," says study investigator Neil Slatkin, M.D., DABPN, Director, Department of Supportive Care, Pain and Palliative Medicine, City of Hope, Duarte, CA. "These data are encouraging for patients living with advanced illnesses who must take opioids to control their pain."

Opioids such as morphine are widely used to lessen the suffering of the approximately 1.7 million Americans living with painful terminal illnesses. In addition to their analgesic effect of blocking the perception of pain within the central nervous system, these medications also interact with opioid-specific receptors outside the brain and spinal cord, resulting in constipation. More than 50 percent of cancer patients admitted to palliative care u
'"/>

Contact: Jennifer Paganelli
jennifer.paganelli@edelman.com
973-296-9083
Edelman Public Relations
23-May-2006


Page: 1 2

Related medicine news :

1. Late-breaking clinical trials
2. Late-breaking science presented at 57th AAN Annual Meeting
3. Digestive Disease Week 2006 highlights state of the art research in GI health
4. Digestive problems may impede overweight people from exercising
5. NIH establishes National Commission on Digestive Diseases
6. NIH launches National Commission on Digestive Diseases
7. Digestive Disease Week 2005 spotlights breakthrough research in digestive health
8. Disease management programs improve long-term outcomes
9. Darveau receives Periodontal Disease Research Award
10. Case Western Reserve University hosts 100th Anniversary of Alzheimers Disease Conference
11. IOS Press presents commemorative volume on Alzheimers Disease to her majesty, Queen Sofia of Spain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2019)... Fla. (PRWEB) , ... August 23, 2019 , ... ... a strategic partnership with the West Virginia Eye Collaborative. This partnership will be ... value, and access of care, the WV Eye Collaborative and its eye physicians ...
(Date:8/21/2019)... ... August 21, 2019 , ... ... new location in Huntsville, Ala. in early 2020. Alsana will offer an eating ... an Intensive Outpatient Program (IOP). The integrative program will provide a continuum of ...
(Date:8/21/2019)... ... August 21, 2019 , ... ... Sunday, July 28. The Phase II expansion of Providence Point in Pittsburgh’s Scott ... well as construction of the 70-unit apartment tower, Hamilton Tower. , ...
(Date:8/19/2019)... ... , ... Professional Enrollment Concepts (PEC), a top benefits enrollment ... ranked #3056 on the 2019 Inc. 5000 Fastest-Growing Private Companies list. The list ... successful companies within the American economy's most dynamic segment—its independent small and mid-sized ...
(Date:8/17/2019)... Fla. (PRWEB) , ... August 17, 2019 , ... ... Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd ... 2098 With Three-Year Revenue Growth of 192% Percent , Inc. magazine today revealed ...
Breaking Medicine News(10 mins):
(Date:8/21/2019)... ... August 21, 2019 , ... Impact Advisors , a ... announced today that it has been named to Inc. magazine’s Inc. 5000 list. The ... for-profit companies with significant percentage revenue growth. This year the firm was also named ...
(Date:8/19/2019)... ... August 19, 2019 , ... ... today announced the findings of research validating the clinical impact of MedAware’s machine ... published 7 August 2019 in the Journal of American Medical Informatics Association ...
(Date:8/19/2019)... ... 19, 2019 , ... The International Association of Eating Disorders ... the field of treatment for eating disorders, recommends membership for professionals who are ... a similar mission. , Founded in 1985, the iaedp™ Foundation is the ...
Breaking Medicine Technology:
Cached News: